|
| | Publication Year | Title | Author(s) |
| 1 | 7-Aug-2023 | Patterns of care for people with small cell lung cancer in Victoria, 2011-19: a retrospective, population-based registry data study. | Huang, Joanna; Faisal, Wasek; Brand, Margaret; Smith, Shantelle; Alexander, Marliese; Briggs, Lisa; Conron, Matthew; Duffy, Mary; John, Thomas ; Langton, David; Lesage, Jacqueline; MacManus, Michael; Mitchell, Paul L R ; Olesen, Inger; Parente, Phillip; Philip, Jennifer; Samuel, Evangeline; Torres, Javier; Underhill, Craig R; Zalcberg, John R; Harden, Susan; Stirling, Rob |
| 2 | Dec-2022 | A Multi-Center Real-World Experience of IMpower150 in Oncogene Driven Tumors and CNS Metastases. | Itchins, Malinda; Ainsworth, Hannah; Alexander, Marliese; Dean, Samantha; Dharmaraj, Devi; Pavlakis, Nick; Clarke, Stephen J; Brown, Chris; Torres, Javier; Saqib, Ayesha; Ladwa, Rahul; O'Byrne, Kenneth; Moore, Melissa; Yip, Po Yee; Solomon, Ben; John, Tom ; Kao, Steven; Mitchell, Paul L R ; Parakh, Sagun |
| 3 | May-2022 | Loss of STING expression is prognostic in non-small cell lung cancer. | Lohinai, Zoltan; Dora, David; Caldwell, Charles; Rivard, Christopher J; Suda, Kenichi; Yu, Hui; Rivalland, Gareth; Ellison, Kim; Rozeboom, Leslie; Dziadziuszko, Rafal; Mitchell, Paul L R ; John, Thomas ; Millan, Inigo S; Ren, Shengxiang; Hirsch, Fred R |
| 4 | Aug-2020 | NTRK and ALK rearrangements in malignant pleural mesothelioma, pulmonary neuroendocrine tumours and non-small cell lung cancer. | Leal, Jose Luis; Peters, Geoffrey; Szaumkessel, Marcin; Leong, Trishe Y-M; Asadi, Khashayar ; Rivalland, Gareth; Do, Hongdo; Senko, Clare ; Mitchell, Paul L R ; Quing, Chai Zi; Dobrovic, Alexander ; Thapa, Bibhusal ; John, Thomas |
| 5 | Mar-2020 | Occult Gastrointestinal Perforation in a Patient With EGFR-Mutant Non-Small-Cell Lung Cancer Receiving Combination Chemotherapy With Atezolizumab and Bevacizumab: Brief Report. | Gunjur, Ashray ; Chong, Geoffrey ; Lim, Adeline ; Lau, Eddie ; Mitchell, Paul L R ; John, Thomas ; Arulananda, Surein |
| 6 | Dec-2019 | RET-rearranged non-small-cell lung cancer and therapeutic implications. | Loh, Zoe ; Mitchell, Paul L R ; John, Thomas ; Arulananda, Surein |
| 7 | Sep-2019 | DDR Alterations as a Surrogate Marker for TMB in SCLC - Use it or Lose it? | Arulananda, Surein; Mitchell, Paul L R ; John, Thomas |
| 8 | Apr-2019 | Mesenchyme to epithelial transition protein expression, gene copy number and clinical outcome in a large non-small cell lung cancer surgical cohort. | Rivalland, Gareth; Mitchell, Paul L R ; Murone, Carmel ; Asadi, Khashayer; Morey, Adrienne L; Starmans, Maud; Boutros, Paul C; Walkiewicz, Marzena; Solomon, Benjamin; Wright, Gavin; Knight, Simon; John, Thomas |
| 9 | Nov-2017 | Combination Osimertinib and Gefitinib in C797S and T790M EGFR-Mutated Non-Small Cell Lung Cancer. | Arulananda, Surein; Do, Hongdo; Musafer, Ashan; Mitchell, Paul L R ; Dobrovic, Alexander ; John, Thomas |
| 10 | Sep-2017 | De novo activating epidermal growth factor mutations (EGFR) in small-cell lung cancer. | Thai, Alesha; Chia, Puey L; Russell, Prudence A; Do, Hongdo; Dobrovic, Alexander ; Mitchell, Paul L R ; John, Thomas |
| 11 | Aug-2017 | Outcomes for patients with synchronous and metachronous primary lung cancer after diagnosis of head and neck cancer. | Tamjid, Babak ; Phan, Phuong L; John, Thomas ; Mitchell, Paul L R ; Gan, Hui K |
| 12 | Aug-2017 | Treatment of ALK-rearranged non-small cell lung cancer: A review of the landscape and approach to emerging patterns of treatment resistance in the Australian context | Itchins, M; Chia, Puey Ling ; Hayes, SA; Howell, VM; Gill, AJ; Cooper, WA; John, Thomas ; Mitchell, Paul L R ; Millward, M; Clarke, SJ; Solomon, B; Pavlakis, N |
| 13 | 22-Apr-2017 | PD-L1 and tumor infiltrating lymphocytes as prognostic markers in resected NSCLC | Ameratunga, Malaka; Asadi, Khashayar ; Lin, Xihui; Walkiewicz, Marzena; Murone, Carmel ; Knight, Simon; Mitchell, Paul L R ; Boutros, Paul; John, Thomas |
| 14 | 2017 | The Immune Microenvironment, Genome-wide Copy Number Aberrations, and Survival in Mesothelioma. | Thapa, Bibhusal ; Salcedo, Adriana; Lin, Xihui; Walkiewicz, Marzena; Murone, Carmel ; Ameratunga, Malaka; Asadi, Khashayar ; Deb, Siddhartha; Barnett, Stephen A ; Knight, Simon; Mitchell, Paul L R ; Watkins, D Neil; Boutros, Paul C; John, Thomas |
| 15 | Dec-2016 | Lung cancer in 2016: immunotherapy comes of age | Mitchell, Paul L R ; John, Thomas |
| 16 | Dec-2016 | Calretinin but not caveolin-1 correlates with tumour histology and survival in malignant mesothelioma. | Thapa, Bibhusal ; Walkiewicz, Marzena; Murone, Carmel ; Asadi, Khashayar ; Deb, Siddhartha; Barnett, Stephen A ; Knight, Simon R ; Mitchell, Paul L R ; Liew, Danny; Watkins, D Neil; John, Thomas |
| 17 | 18-Oct-2016 | Digital PCR of genomic rearrangements for monitoring circulating tumour DNA | Do, Hongdo; Cameron, Daniel; Molania, Ramyar; Thapa, Bibhusal ; Rivall, Gareth; Mitchell, Paul L R ; Murone, Carmel ; John, Thomas ; Papenfuss, Anthony; Dobrovic, Alexander |
| 18 | Aug-2016 | Temporal changes of EGFR mutations and T790M levels in tumour and plasma DNA following AZD9291 treatment | Chia, Puey Ling ; Do, Hongdo; Morey, Adrienne; Mitchell, Paul L R ; Dobrovic, Alexander ; John, Thomas |
| 19 | 20-Nov-2014 | Prevalence and natural history of ALK positive non-small-cell lung cancer and the clinical impact of targeted therapy with ALK inhibitors. | Chia, Puey Ling ; Mitchell, Paul L R ; Dobrovic, Alexander ; John, Thomas |
| 20 | 26-Feb-2014 | A critical re-assessment of DNA repair gene promoter methylation in non-small cell lung carcinoma. | Do, Hongdo; Wong, Nicholas C; Murone, Carmel ; John, Thomas ; Solomon, Benjamin J; Mitchell, Paul L R ; Dobrovic, Alexander |
Loading...
2
0
20
0
false